- Home
- CIM vs IART Comparison
CIM vs IART Comparison
Compare CIM & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CIM | IART |
|---|---|---|
| Founded | 2007 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 933.9M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | CIM | IART |
|---|---|---|
| Price | $13.55 | $12.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $15.25 | $15.00 |
| AVG Volume (30 Days) | ★ 969.2K | 679.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 10.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.42 | $3.26 |
| Revenue Next Year | $27.67 | $2.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.85 | $10.60 |
| 52 Week High | $14.88 | $25.45 |
Technical Indicators
Market Signals| Indicator | CIM | IART |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 55.30 |
| Support Level | $13.43 | $10.60 |
| Resistance Level | $14.18 | $12.20 |
| Average True Range (ATR) | 0.36 | 0.56 |
| MACD | 0.12 | 0.18 |
| Stochastic Oscillator | 70.41 | 90.94 |
Price Performance
Historical ComparisonAbout CIM Chimera Investment Corporation
Chimera Investment Corporation is a real estate investment trust engaged in investing in a portfolio of mortgage assets on a leveraged basis. These investments include a variety of government-sponsored agency residential mortgage-backed securities, or RMBS, non-agency RMBS, agency commercial mortgage-backed securities, residential mortgage loans, and other real estate-related securities. Agency mortgage-backed securities represent the share of this portfolio, while subprime residential mortgage loans and non-agency RMBS also make up substantial shares.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.